由科医人医疗激光公司主要赞助,国际美容皮肤科学会,中华医学会和中华医学会医学美学与美容学分会主办的第三届国际美容皮肤科学大会,于2003年12月7-10日在北京国际会议中心召开。

大会日程安排： 12月7日晚 12月8日晚 12月9日 12月10日

人民大会堂金色大厅宴会 VIP晚宴 （在北京之夜） 科医人卫星会Lumenis Laser Therapy 中午 大会结束

这是科医人公司本年度举办的最后一次与美容业务相关的，也是最大的一次皮肤美容国际盛会，我们对这个会的重视不仅表现在赞助力度、展位装饰上，更重要的是，科医人在这个会上推出LumenisOne这一全球最尖端的激光美容仪，同时继续宣传全球唯一有效的Relume和现在市场热衷的Quantum+Lightsheer。并且我公司还邀请了美国著名的皮肤科医生Dr.Gold以及科医人公司负责全球市场的业务发展的Robert Ruck与会做专题学术演讲，同时在卫星会上除了Dr.Gold，还有我们邀请出席的香港、台湾地区的知名美容专家。并包含了多个主题报告会和学术演讲会。是一次云集了国内外1000多名美容皮肤学方面专家的国际学术盛会。

Plastic Surgery Catches on US company puts high hopes on China market With China’s first plastic beauty Hao Lulu still in the media limelight, Avner Raz, president and chief executive officer of Lumenis – the world’s leader in aesthetic and medical laser equipment – brought his company’s latest product to Beijing last week. The United States may be the biggest market for cosmetic surgery in the world, but the Asia-Pacific area is the second. As proof of that, Raz, Now in his third visit in six months, has brought his company’s latest product, LumenisOne, into China. This is the only market outside the United States where the product has been introduced. “China is so big and Chinese people are becoming more and more aware of the necessities of using such equipment,” Raz said. Take Hao’s example. The Beijing woman has been undergoing a 200-day-long marathon duckling-to-swan series of surgeries at the Beijing EverCare Cosmetic Surgery Hospital and Clinic. Lumenis provides the clinic’s equipment.Raz expects his company’s sales in the Chinese market to double in the next three years. Zhai Qiying, the US company’s executive vice-president who has been taking charge of the company’s China operations, is even more ambitious, hoping sales will multiply by three during the period. This year, the company is expected to reap US$26 million in China, according to Zhai.That will represent a 30 percent rise from last year. Zhai’s confidence is based on the fast growing number of consumers who are paying big money to make themselves look better and younger. Industry analysts say the cosmetic surgery industry has progressed dramatically in China in recent years. Statistics from the China Plastic Cosmetology Committee show there are more than 10,000 medical institutions carrying out procedures throughout the country. Revenues of about 2 billion yuan (US$240 million) have piled up since procedures were first offered in the country. That explains Raz’s frequent visit to China and the company’s move to introduce its latest product into the Chinese market last week. Lumenis’ major global rivals such as Candela from the United States, have also entered the Chinese market. The just-concluded Third World Congress of International Academy of Cosmetic Dermatology in Beijing also gathered the world’s experts and top equipment producers in this field. “If you look around the world for your future market, you will get China and the Asia-Pacific area,” Raz said. “China, Japan and Far East are our biggest potential markets.” The United States is still the world’s largest market. Raz’s company hit about US$150 million in sales there every year. But Asia-Pacific is the second largest one. Raz said if his company’s sales in China reach US$50 million a year, Lumenis will set up plants in China to manufacture the equipment as local production can make customer service easier and cheaper. “Sales of US$50 million will be enough for us to make a determination to produce the equipment here,” Zhai said. The company also plans to introduce laser equipment into China’s dental market. The Company entered the Chinese market in 1991 and has established eight offices in big cities such as Beijing and Shanghai.